Understanding Timing Deficits in Parkinson's Disease
Author Information
Author(s): Harrington Deborah L., Castillo Gabriel N., Greenberg Paul A., Song David D., Lessig Stephanie, Lee Roland R., Rao Stephen M.
Primary Institution: University of California San Diego
Hypothesis
How do dopamine therapy and brain activity affect time perception in individuals with Parkinson's disease?
Conclusion
Impaired timing in Parkinson's disease is linked to dysfunction in specific brain regions, and dopamine therapy does not improve these timing deficits.
Supporting Evidence
- Time-perception deficits were linked to striatal, cortical, and cerebellar dysfunction.
- Dopamine therapy did not alleviate timing deficits in Parkinson's disease.
- Participants showed abnormal activation in brain networks associated with working memory and executive functions.
Takeaway
People with Parkinson's disease have trouble telling time because their brains don't work like they should, and taking medicine doesn't help fix this problem.
Methodology
Participants underwent fMRI while performing a time-perception task, comparing brain activity in Parkinson's patients on and off dopamine therapy.
Potential Biases
Potential selection bias in participant recruitment and exclusion criteria.
Limitations
The study may not generalize to all Parkinson's patients, and the effects of other medications were not controlled.
Participant Demographics
21 volunteers with idiopathic Parkinson's disease (14 males, 7 females) and 19 healthy adults (12 males, 7 females).
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website